Evidence map›Paper›PMID 26742780›Full record

ArticleThe EMBO journal2016

Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling.

Celio X C Santos, Anne D Hafstad, Matteo Beretta, Min Zhang, Chris Molenaar, Jola Kopec, Dina Fotinou, Thomas V Murray, Andrew M Cobb, Daniel Martin and 13 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Reactive oxygen species in hypertension.Nature reviews. Cardiology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 5 institutions in 4 countries.

Celio X C SantosCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Anne D HafstadCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK Cardiovascular Research Group, Department of Medical Biology, The Arctic University of Norway, Tromsø, Norway.
Matteo BerettaCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Min ZhangCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Chris MolenaarCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Jola KopecCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK Randall Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Dina FotinouCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK Randall Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Thomas V MurrayCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Andrew M CobbCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Daniel MartinCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Maira Zeh SilvaCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK Randall Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Narayana AnilkumarCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Katrin SchröderInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Catherine M ShanahanCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Alison C BrewerCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Ralf P BrandesInstitute for Cardiovascular Physiology, Goethe-University, Frankfurt, Germany.
Eric BlancMRC Centre for Developmental Neurobiology, King's College London, London, UK.
Maddy ParsonsRandall Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Vsevelod BelousovShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.
Richard CammackInstitute of Pharmaceutical Science, King's College London, London, UK.
Robert C HiderInstitute of Pharmaceutical Science, King's College London, London, UK.
Roberto A SteinerRandall Division, King's College London British Heart Foundation Centre of Excellence, London, UK.
Ajay M ShahCardiovascular Division, King's College London British Heart Foundation Centre of Excellence, London, UK ajay.shah@kcl.ac.uk.
British Heart Foundation · GBKing's College London · GBGoethe University Frankfurt · DEInstitute of Bioorganic Chemistry · RUUiT The Arctic University of Norway · NO

Funding

British Heart Foundation PG/11/124/29318British Heart Foundation PG/12/26/29477British Heart Foundation PG/15/27/31374British Heart Foundation RE/13/2/30182British Heart Foundation RG/13/11/30384Department of Health
6 · The paper itself

Abstract

Phosphorylation of translation initiation factor 2α (eIF2α) attenuates global protein synthesis but enhances translation of activating transcription factor 4 (ATF4) and is a crucial evolutionarily conserved adaptive pathway during cellular stresses. The serine-threonine protein phosphatase 1 (PP1) deactivates this pathway whereas prolonging eIF2α phosphorylation enhances cell survival. Here, we show that the reactive oxygen species-generating NADPH oxidase-4 (Nox4) is induced downstream of ATF4, binds to a PP1-targeting subunit GADD34 at the endoplasmic reticulum, and inhibits PP1 activity to increase eIF2α phosphorylation and ATF4 levels. Other PP1 targets distant from the endoplasmic reticulum are unaffected, indicating a spatially confined inhibition of the phosphatase. PP1 inhibition involves metal center oxidation rather than the thiol oxidation that underlies redox inhibition of protein tyrosine phosphatases. We show that this Nox4-regulated pathway robustly enhances cell survival and has a physiologic role in heart ischemia-reperfusion and acute kidney injury. This work uncovers a novel redox signaling pathway, involving Nox4-GADD34 interaction and a targeted oxidative inactivation of the PP1 metal center, that sustains eIF2α phosphorylation to protect tissues under stress.

Indexed as

Signal TransductionAnimalsCell LineEukaryotic Initiation Factor-2HumansNADPH Oxidase 4NADPH OxidasesOxidation-ReductionProtein Phosphatase 1Receptors, Neuropeptide YEukaryotic Initiation Factor-2NADPH Oxidase 4NADPH Oxidasesneuropeptide Y4 receptorNOX4 protein, humanPPP1R15A protein, humanProtein Phosphatase 1Receptors, Neuropeptide YeIF2αmetal centerNox4protein phosphataseredox signaling

Identifiers

PMID26742780
PMCPMC4741303
OpenAlexW2224592948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.